Form 4: VolitionRx CEO Salvatore Thomas Butera Reports Stock Transaction
SEC Form 4 Filing
CEO Salvatore Thomas Butera of VolitionRx Ltd. reports disposition of shares to cover tax obligations related to restricted stock units.
Summary
- On May 1, 2024, Salvatore Thomas Butera, CEO of Volition Veterinary and an officer of VolitionRx Ltd., reported a transaction involving the company's common stock.
- Butera disposed of 15,504 shares to cover tax withholding obligations upon the settlement of 50,000 restricted stock units.
- The shares were disposed of at a price of $0.87.
- Following the transaction, Butera directly owns 199,494 shares of VolitionRx Ltd.
- Butera also jointly owns 99,350 shares with his spouse.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing relates to a routine transaction for tax purposes and doesn't indicate a change in the executive's overall investment in the company.
Industry Context
This filing is a routine disclosure related to executive compensation and tax obligations, and doesn't necessarily reflect a change in the executive's long-term outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 05/01/2024 | Date of stock transaction (disposal of shares for tax obligations). |
| 05/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.